-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Downgrades Rocket Pharmaceuticals to Underweight

Benzinga·11/18/2025 15:28:25
Listen to the news
JP Morgan analyst Tessa Romero downgrades Rocket Pharmaceuticals (NASDAQ:RCKT) from Neutral to Underweight.